Search
Displaying results 1051 to 1060 of 1203.
Investigation of a SARS-CoV-2 outbreak in German meat processing plant published in scientific journal
In an expert statement, Prof Melanie Brinkmann, head of the research group "Viral Immune Modulation" at the HZI, comments on the results: “Our investigation of a SARS-CoV-2 outbreak in the meat industry shows that the conditions in the processing plant - physical work,…
Emmanuelle Charpentier Honored With the 2020 Nobel Prize in Chemistry
"We are very pleased that Emmanuelle Charpentier's outstanding scientific achievements are now also being honoured by the Royal Swedish Academy of Sciences," says Dirk Heinz, Scientific Director of the HZI. "The CRISPR-Cas9 system has a huge impact on genetic…
Together we can do it: Each individual contribution protects health, society, and the economy
But one thing is sure: The COVID pandemic is dynamic. Containment measures must therefore be continuously monitored and adapted. In order to help overcome the epidemic and close gaps in knowledge, modelling experts from the non-university research organizations – the…
HZI nationwide coronavirus antibody study comes to Aachen
The actual spread of the novel coronavirus SARS-CoV-2 is only partially recorded by official statistics. In order to gain a better overview of the infection process, a nationwide antibody study has been running at the HZI since July. The MuSPAD project (Multi-local and…
PhD-Programm BIOMEDAS gestartet
In der digitalen Talkrunde waren sich Heike von der Heide (Niedersächsisches Ministerium für Wissenschaft und Kultur), Dr. Jennifer Debarry (Vorsitzende im BIOMEDAS Strategieausschuss, Koordinatorin des Centre for Individualised Infection Medicine (CiiM)), Prof. Ulrich…
Three ERC Starting Grants awarded to HZI
This year, three of the renowned ERC Starting Grants were awarded to the Helmholtz Centre for Infection Research (HZI). These grants from the European Research Council (ERC) are specifically designed to help young scientists and researchers make the leap to independent…
Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
As a member of the CARE consortium, the Helmholtz Centre for Infection Research (HZI) will contribute its expertise in pharmacology of anti-infective compounds. Its Pharmacokinetics/Pharmacodynamics unit (PK/PD unit), that has been initiated by the German Center for…
COVID-19: Immune system derails
Most patients infected with the coronavirus SARS-CoV-2 show mild or even no symptoms. However, 10 to 20 percent of patients develop pneumonia during the course of COVID-19 disease, some of them with life-threatening consequences. "There is still not very much known…
How many people are now immune to SARS-CoV-2?
The strategies for dealing with the COVID-19 pandemic depend largely on estimation of the actual number of infected people. In addition to the cases tested and confirmed, there is an unknown number of people who have undergone infection with or without mild symptoms and…
Exploring the RNA world of the microbiota
In the human intestine, countless bacteria form a complex community. B. theta is one of the most abundant species there and relatively easy to study in the lab. ”Until now, no fine-grained transcriptome annotation – a map of the entirety of RNA molecules – was…
